Sorrento Therapeutics Inc (SRNE)

[dia76ca]

On Jan.16 Sorrento advertised for two scientists for it's 50% owned Cytimm Therapeutics. What are they up to? The latest information I could find was a presentation made by their Co-founder and CSO Haining Huang in March 2022...as follows.

CTM101, Next Generation IL-2Rß? Selective IL-2
Derivative for Cancer Therapy
• Site-specific PEGylation of IL2 without affecting its function
• Complete abolished alpha activity led to better CD8 activation with minimum toxicity
• CHO cell manufacturing gave good yield with high stability and low aggregation
Haining Huang, Chief Scientific Officer, Cytimm Therapeutics, Inc.

Dr. Huang was formerly employed as a Scientist at Sorrento. If they are hiring two scientists something must going right! Another arrow in the Sorrento quiver!